创新药概念震荡下挫 常山药业跌超15%

Group 1 - The innovative drug concept sector experienced a significant decline in early trading on November 4, with Changshan Pharmaceutical dropping over 15% [1] - Other companies in the sector, including Yuandong Biological, Rejing Biological, Baiyang Pharmaceutical, Yipinhong, and Sanofi Guojian, saw declines exceeding 4% [1]